MTOR and head and neck squamous cell carcinoma: This study shows that high p-mTOR expression predicts and p-ERK expression tends to predict worse treatment outcome in a cohort of advanced stage, HPV negative HNSCC patients treated with chemoradiation, providing additional evidence that these markers are candidate prognostic biomarkers for survival in this patient population.